Recent evidence suggests that decreased EphA5 expression is associated with nodal metastasis, advanced TNM stages and unfavorable prognosis in CRC, implicating EphA5 as a potential tumor suppressor (44). This evidence concerns the gene EPHA5 and neoplasm.